Restructuring Roundup: Repros Therapeutics Inc...Basilea Pharmaceutica International Ltd.'s case against Johnson & Johnson for messing up development of the antibiotic ceftobiprole got a boost when the FDA slapped J&J with a warning letter for clinical trial conduct...got smacked with another FDA clinical hold on its planned Phase I trial of human embryonic stem cell-based therapy GRNOPC1 in spinal cord injury